Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis

Autor: Cottone, Lucia, Capobianco, Annalisa, Gualteroni, Chiara, Monno, Antonella, Raccagni, Isabella, Valtorta, Silvia, Canu, Tamara, Di Tomaso, Tiziano, Lombardo, Angelo, Esposito, Antonio, Moresco, Rosa Maria, Del Maschio, Alessandro, Naldini, Luigi, Rovere-Querini, Patrizia, Bianchi, Marco E., Manfredi, Angelo A.
Přispěvatelé: Cottone, L, Capobianco, A, Gualteroni, C, Monno, A, Raccagni, I, Valtorta, S, Canu, T, Tomaso, T, Lombardo, A, Esposito, A, Moresco, R, Maschio, A, Naldini, L, Rovere Querini, P, Bianchi, M, Manfredi, A, De Tomaso, T, Lombardo, ANGELO LEONE, Esposito, Antonio, Moresco, Rm, DEL MASCHIO, Alessandro, Naldini, Luigi, ROVERE QUERINI, Patrizia, Bianchi, MARCO EMILIO, Manfredi, ANGELO ANDREA M. A.
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
green fluorescent protein
Pathology
medicine.medical_specialty
Murine colon adenocarcinoma cell line
Phagocyte
Macrophage
Immunology
Damage-associated molecular pattern
chemical and pharmacologic phenomena
High Mobility Box 1
macrophage
HMGB1
GFP
BoxA
damage-associated molecular pattern
Small hairpin RNA
03 medical and health sciences
0302 clinical medicine
vascularization
In vivo
Leukocytes
medicine
Extracellular
DAMP
short hairpin RNA
Immunology and Allergy
MC-38
murine colon adenocarcinoma cell line
Original Research
Gene knockdown
peritoneal carcinomatosi
biology
business.industry
Macrophages
Tumor-Derived
Leukocyte
030104 developmental biology
medicine.anatomical_structure
Alarmin
Oncology
030220 oncology & carcinogenesis
biology.protein
ShRNA
business
leukocyte
Peritoneal carcinomatosis
Zdroj: ONCOIMMUNOLOGY 5 (2016): e1122860. doi:10.1080/2162402X.2015.1122860
info:cnr-pdr/source/autori:Cottone, Lucia; Cottone, Lucia; Capobianco, Annalisa; Gualteroni, Chiara; Monno, Antonella; Raccagni, Isabella; Raccagni, Isabella; Valtorta, Silvia; Valtorta, Silvia; Canu, Tamara; Di Tomaso, Tiziano; Lombardo, Angelo; Lombardo, Angelo; Esposito, Antonio; Esposito, Antonio; Moresco, Rosa Maria; Moresco, Rosa Maria; Del Maschio, Alessandro; Del Maschio, Alessandro; Naldini, Luigi; Naldini, Luigi; Rovere-Querini, Patrizia; Rovere-Querini, Patrizia; Bianchi, Marco E.; Bianchi, Marco E.; Manfredi, Angelo A.; Manfredi, Angelo A./titolo:Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis/doi:10.1080%2F2162402X.2015.1122860/rivista:ONCOIMMUNOLOGY/anno:2016/pagina_da:e1122860/pagina_a:/intervallo_pagine:e1122860/volume:5
DOI: 10.1080/2162402X.2015.1122860
Popis: The factors that determine whether disseminated transformed cells in vivo yield neoplastic lesions have only been partially identified. We established an ad hoc model of peritoneal carcinomatosis by injecting colon carcinoma cells in mice. Tumor cells recruit inflammatory leukocytes, mostly macrophages, and generate neoplastic peritoneal lesions. Phagocyte depletion via clodronate treatment reduces neoplastic growth. Colon carcinoma cells release a prototypic damage-associated molecular pattern (DAMP)/alarmin, High Mobility Group Box1 (HMGB1), which attracts leukocytes. Exogenous HMGB1 accelerates leukocyte recruitment, macrophage infiltration, tumor growth and vascularization. Lentiviral-based HMGB1 knockdown or pharmacological interference with its extracellular impair macrophage recruitment and tumor growth. Our findings provide a preclinical proof of principle that strategies based on preventing HMGB1-driven recruitment of leukocytes could be used for treating peritoneal carcinomatosis.
Databáze: OpenAIRE